What changed in this filing

/stocks — the workspaceLOADING

Item 2. Unregistered Sales of Equity Securities

2024-08-14 compared with 2024-05-15 · 34 added, 30 removed, 54 unchanged (54% of the section changed)

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS .

SALES OF EQUITY SECURITIES AND USE OF PROCEEDS .

Use of Proceeds

25 unchanged sentences

for resale by the selling stockholders named in the IPO Registration Statement and the related Final Resale Prospectus.

As stated in the

Final Resale Prospectus, any resales of these shares occurred at a fixed price of $5.00 per share until the Class B Common Stock was listed

Thereafter, these sales will occur at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing

market prices, or at negotiated prices.

The Company would not receive any proceeds from the resale of Class B Common Stock by the selling

stockholders.

Any resales of

these shares occurred at a fixed price of $25.00 per share until the Class B Common Stock was listed on Nasdaq.

Thereafter, these sales

will occur at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market prices, or at negotiated

The Company will not receive any proceeds from the resale of Class B Common Stock by the selling stockholders.

The IPO Registration Statement also registered

for sale shares of Class B Common Stock with a maximum aggregate offering price of $1,125,000 for an additional 45,000 shares of Class

B Common Stock at the assumed public offering price of $5.00 per share upon full exercise of the underwriters’ over-allotment option;

and up to an additional 15,750 shares of Class B Common Stock underlying the Representative’s Warrant with a maximum aggregate offering

price of $98,437.50 at the assumed exercise price of $6.25 per share assuming full exercise of the over-allotment option .

The underwriters’ over-allotment option expired unexercised.

The Company has not received any proceeds from the exercise

of the Representative’s Warrant because it has not been exercised.

B Common Stock at the assumed public offering price of $25.00 per share upon full exercise of the underwriters’ over-allotment

and up to an additional 3,150 shares of Class B Common Stock underlying the Representative’s Warrant with a maximum aggregate

offering price of $98,437.50 at the assumed exercise price of $31.25 per share assuming full exercise of the over-allotment option.

underwriters’ over-allotment option expired unexercised.

The Company has not received any proceeds from the exercise of the Representative’s

Warrant because it has not been exercised.

On April 4, 2023, the Post-Effective Amendment

was filed with the SEC and became effective on April 14, 2023.

The Post-Effective Amendment was required to be filed to update the IPO Registration Statement

to include, among other things, the information contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022,

which was filed with the SEC on March 31, 2023.

The Post-Effective Amendment maintained the effectiveness of the IPO Registration

Statement with respect to the sale of shares of common stock issuable upon exercise of the Representative’s Warrant and

the resale of the shares of common stock held by the selling stockholders.

The Post-Effective Amendment was required to be filed to update the IPO

Registration Statement to include, among other things, the information contained in our Annual Report on Form 10-K for the fiscal year

ended December 31, 2022, which was filed with the SEC on March 31, 2023.

The Post-Effective Amendment maintained the effectiveness

of the IPO Registration Statement with respect to the sale of shares of common stock issuable upon exercise of the Representative’s

Warrant and the resale of the shares of common stock held by the selling stockholders.

Updated prospectuses were included with the Post-Effective

The Post-Effective Amendment also incorporates by reference all documents subsequently filed by the Company pursuant to Sections

13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering described in the prospectuses included with the

Post-Effective Amendment.

As stated in the IPO

6 unchanged sentences

The following is the

Company’s reasonable estimate of the uses of the proceeds from the initial public offering from the date of the closing of the offering

on February 7, 2023 through March 31, 2024:

None was used for construction of plant, building and facilities;

None was used for the purchase and installation of machinery and equipment;

None was used for purchases of real estate;

Company’s reasonable estimate of the uses of the proceeds from the initial public offering from the date of the closing of the

offering on February 7, 2023 through June 30, 2024:

was used for construction of plant, building and facilities;

was used for the purchase and installation of machinery and equipment;

was used for purchases of real estate;

was used for the acquisition of other businesses;

None was used for the repayment of indebtedness;

was used for the repayment of indebtedness;

● Approximately

$5.1 million was used for working capital;

None was used for temporary investments.

was used for temporary investments.

As of the date of this report, none of the proceeds from the initial public offering were used to make direct or indirect payments to

5 unchanged sentences

Unregistered Sales of Equity Securities

During the three months ended March 31, 2024,

During the three months ended June 30, 2024,

we did not sell any equity securities that were not registered under the Securities Act and that were not previously disclosed in a Current

1 unchanged sentence

Purchases of Equity Securities

No repurchases

of our common stock were made during the three months ended March 31, 2024.

DEFAULTS UPON SENIOR SECURITIES.

No repurchases of our common stock were made

during the three months ended June 30, 2024.

DEFAULTS UPON

SENIOR SECURITIES.

MINE SAFETY DISCLOSURES.

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Unregistered Sales of Equity Securities